MILWAUKEE, Oct. 21, 2019 /PRNewswire/ -- Ademi &
O'Reilly, LLP is investigating Innophos (NASDAQ: IPHS) for
possible breaches of fiduciary duty and other violations of the law
in connection with the sale of Innophos to One Rock.
Click here to learn how to join the action:
http://ademilaw.com/case/innophos-holdings-inc or call Guri Ademi toll-free at 866-264-3995.
There is no cost or obligation to you.
Ademi & O'Reilly, LLP alleges Innophos's financial outlook
is improving and yet shareholders will receive only $32.00 per share in cash in a transaction valued
at approximately $932 million,
including the assumption of debt. One Rock is acquiring
Innophos at a substantial discount. The merger agreement
unreasonably limits competing bids for Innophos by prohibiting
solicitation of further bids, and imposing a termination penalty if
Innophos accepts a superior bid. Innophos insiders will receive
millions of dollars as part of change of control arrangements. We
are investigating on the conduct of Innophos' board of directors,
and whether they are (i) fulfilling their fiduciary duties to all
shareholders, and (ii) obtaining a fair and reasonable price for
Innophos.
If you own common stock in Innophos and wish to obtain
additional information, please contact Guri
Ademi either at gademi@ademilaw.com or toll-free:
866-264-3995, or
http://ademilaw.com/case/innophos-holdings-inc.
We specialize in shareholder litigation involving buyouts,
mergers, and individual shareholder rights throughout the country.
For more information, please feel free to call us. Attorney
advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi & O'Reilly, LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
View original
content:http://www.prnewswire.com/news-releases/shareholder-alert-ademi--oreilly-llp-investigates-whether-innophos-holdings-inc-has-obtained-a-fair-price-in-its-sale-to-one-rock-capital-partners-llc-300941964.html
SOURCE Ademi & O'Reilly, LLP